Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

SHOCKING: What to expect from resmed s next quarterly earnings report - You Need To See This

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders. Valued at a market cap of $41.1 billion, the company is scheduled to announce its fiscal Q1 earnings for 2026 in the near future. 

Before this event, analysts expect this healthcare company to report a profit of $2.49 per share, up 13.2% from $2.20 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $2.55 per share in the previous quarter topped the consensus estimates by 3.7%. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.